Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in adults with uncomplicated malaria
30 Mar, 2018 | 04:16h | UTCSafety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial – The Lancet Infectious Diseases (free registration required)
Commentaries: Ivermectin: repurposing an old drug to complement malaria vector control – The Lancet Infectious Diseases (free registration required) AND LSTM study shows drug that kills mosquitoes could be used to fight malaria – London School of Tropical Medicine (free) AND Common anti-parasitic could be new tool for malaria control – OnMedica (free)